Search

everythinglearnresearchcommunity

for

Search:↓

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

The microneedle device with rapamycin and epigallocatechin gallate effectively promoted hair regrowth in mice.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Hair loss in postmenopausal woman caused by ovarian issue.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Moderately high prolactin levels do not cause hair loss in women.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.